Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions.
Sphingomyelin (SM) and cholesterol (Chol) are major surface lipid constituents of plasma lipoproteins. We investigated the effects of SM and Chol on the plasma clearance of lipid emulsions as a model for lipoprotein particles in rats. The presence of Chol facilitated the removal of emulsion particles from plasma, whereas SM delayed particle removal. Preinjection of lactoferrin, an inhibitor of the apolipoprotein E (apoE) receptor, revealed that the differences in clearance of emulsions were due to the differences in affinity for the apoE receptor. Measurement of apolipoprotein binding suggested that the balance of apoE and apoC (apoC-II and apoC-III) bound to emulsions caused the difference in plasma clearance of emulsion particles. That is to say, SM in the emulsion surface decreased binding of apoE, which led to a longer circulation of emulsion particles in plasma. Chol, on the other hand, decreased the ratio of apoC to apoE, which may have promoted emulsion uptake through the apoE receptor. We also examined in vitro lipolysis using immobilized lipoprotein lipase (LPL) in a heparin affinity column. Lipolysis rates were significantly reduced by the incorporation of SM into the emulsion surface, but not by the incorporation of Chol, indicating that SM in the lipoprotein surface is an important lipid component regulating LPL-mediated lipolysis. Our results suggest that the presence of SM and Chol in the lipoprotein surface plays an important role in the circulation behavior and LPL-mediated lipolysis of lipid emulsions through their effect on the selectivity of plasma protein binding.
Arimoto
I
I
Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Matsumoto
C
C
Tanaka
M
M
Okuhira
K
K
Saito
H
H
Handa
T
T
D000818:Animals; D001053:Apolipoproteins / Q000378:metabolism; D002784:Cholesterol / Q000494:pharmacology; D005217:Fat Emulsions, Intravenous / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D008066:Lipolysis / Q000502:physiology*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D013109:Sphingomyelins / Q000494:pharmacology; D014304:Triolein / Q000378:metabolism*
D001053:Apolipoproteins; D005217:Fat Emulsions, Intravenous; D013109:Sphingomyelins; D014304:Triolein; D002784:Cholesterol